DarioHealth Corp. Warrant
DRIOW
DRIOW was delisted on the 4th of March, 2021.
3 hedge funds and large institutions have $5K invested in DarioHealth Corp. Warrant in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.
150% more capital invested
Capital invested by funds: $2K → $5K (+$3K)
0% more funds holding
Funds holding: 3 → 3 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
Bard Associates
Chicago,
Illinois
|
-$65 |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$34 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BA
1
Bard Associates
Chicago,
Illinois
| $3K | -$65 | -1,500 | -2% |
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $2K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| – | -$34 | -800 | -10% |
|
DRIOW Hedge Fund Activity: Q3 2019 in Review
3 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in DarioHealth Corp. Warrant (DRIOW) for Q3 2019, worth a combined $5K — up 150% from $2K a quarter earlier.
Fund positioning in DRIOW was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was Bard Associates, cutting an estimated $65.
- 3 institutional investors held DarioHealth Corp. Warrant (DRIOW) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $5K of DarioHealth Corp. Warrant stock for Q3 2019, up 150% quarter-over-quarter.
- 0 funds opened new DarioHealth Corp. Warrant positions in Q3 2019 and 0 closed out.
- The largest DarioHealth Corp. Warrant seller in Q3 2019 was Bard Associates, an estimated $65 sold.
Based on aggregated 13F filings for Q3 2019.